ClariTrial | Search Clinical Trials

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

236 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis

Phase 2Atopic Dermatitis

Placebo ComparatorCM512

Keymed Biosciences Co.Ltd200 participants1 site · ChinaCompletes Jul 2026

Compare CT.gov Full analysis →

Recruiting

A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis

Phase 2Atopic Dermatitis

VC005 groupVC005 Placebo group

Jiangsu vcare pharmaceutical technology co., LTD120 participants1 site · ChinaCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

N/AAtopic DermatitisPsoriasisHidradenitis Suppurativa

SamplingSampling

Assistance Publique - Hôpitaux de Paris830 participants1 site · FranceCompletes Nov 2035

Compare CT.gov Full analysis →

Recruiting

Virtual Reality for Pain Management During Dupilumab Injection

N/AAtopic DermatitisPainAnxiety

Virtual Reality DistractionStandard Treatment

St. Justine's Hospital98 participants2 sites · CanadaCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Phase 2Atopic DermatitisAtopic Dermatitis EczemaEczema

IMG-007Placebo

Inmagene LLC405 participants30 sites · United States, Australia, CanadaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Phase 3Atopic Dermatitis

Abrocitinib

Pfizer500 participants41 sites · United States, China, GermanyCompletes Feb 2032

Compare CT.gov Full analysis →

Recruiting

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

N/ACutaneous T-cell LymphomaSezary SyndromeMycosis Fungoides

Blood draw, skin biopsy or urine collection

University of Pittsburgh200 participants1 site · United StatesCompletes Jan 2030

Compare CT.gov Full analysis →

Recruiting

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Phase 3Atopic Dermatitis

Tralokinumab + TCSPlacebo + TCS

LEO Pharma195 participants72 sites · United States, Belgium, CanadaCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa

Phase 2Hidradenitis Suppurativa (HS)

SCT650C

Sinocelltech Ltd.60 participants1 site · Turkey (Türkiye)Completes Mar 2027

Compare CT.gov Full analysis →

Recruiting

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

Phase 4Atopic Dermatitis (Eczema)Psoriasis

Sodium chloride tabletsPlacebo Tablets

University of California, San Francisco50 participants2 sites · United StatesCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

N/AAtopic Dermatitis

Abrocitinib

Pfizer400 participants1 site · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Phase 3Moderate to Severe Atopic Dermatitis

MethotrexatePlacebo

medac GmbH277 participants30 sites · Czechia, France, ItalyCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

Phase 1Atopic Dermatitis (AD)

Onabotulinum Toxin Type A - Phase 1bOnabotulinum Toxin Type A - Phase 2

Daniel Kaplan8 participants2 sites · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis

N/AAtopic Dermatitis (AD)

CeraVe Moisturizing CreamGalenico

Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse98 participants1 site · ItalyCompletes Jul 2026

Compare CT.gov Full analysis →

Recruiting

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

Phase 1Atopic DermatitisHidradenitis Suppurativa (HS)Rheumatoid Arthritis (RA)

QLS12010Placebo

Shanghai Qilu Pharmaceutical Research and Development Center LTD102 participants1 site · ChinaCompletes Dec 2025

Compare CT.gov Full analysis →

1–15 of 236

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

236 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis

Phase 2Atopic Dermatitis

Placebo ComparatorCM512

Keymed Biosciences Co.Ltd200 participants1 site · ChinaCompletes Jul 2026

Compare CT.gov Full analysis →

Recruiting

A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis

Phase 2Atopic Dermatitis

VC005 groupVC005 Placebo group

Jiangsu vcare pharmaceutical technology co., LTD120 participants1 site · ChinaCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

N/AAtopic DermatitisPsoriasisHidradenitis Suppurativa

SamplingSampling

Assistance Publique - Hôpitaux de Paris830 participants1 site · FranceCompletes Nov 2035

Compare CT.gov Full analysis →

Recruiting

Virtual Reality for Pain Management During Dupilumab Injection

N/AAtopic DermatitisPainAnxiety

Virtual Reality DistractionStandard Treatment

St. Justine's Hospital98 participants2 sites · CanadaCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Phase 2Atopic DermatitisAtopic Dermatitis EczemaEczema

IMG-007Placebo

Inmagene LLC405 participants30 sites · United States, Australia, CanadaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Phase 3Atopic Dermatitis

Abrocitinib

Pfizer500 participants41 sites · United States, China, GermanyCompletes Feb 2032

Compare CT.gov Full analysis →

Recruiting

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

N/ACutaneous T-cell LymphomaSezary SyndromeMycosis Fungoides

Blood draw, skin biopsy or urine collection

University of Pittsburgh200 participants1 site · United StatesCompletes Jan 2030

Compare CT.gov Full analysis →

Recruiting

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Phase 3Atopic Dermatitis

Tralokinumab + TCSPlacebo + TCS

LEO Pharma195 participants72 sites · United States, Belgium, CanadaCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa

Phase 2Hidradenitis Suppurativa (HS)

SCT650C

Sinocelltech Ltd.60 participants1 site · Turkey (Türkiye)Completes Mar 2027

Compare CT.gov Full analysis →

Recruiting

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

Phase 4Atopic Dermatitis (Eczema)Psoriasis

Sodium chloride tabletsPlacebo Tablets

University of California, San Francisco50 participants2 sites · United StatesCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

N/AAtopic Dermatitis

Abrocitinib

Pfizer400 participants1 site · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Phase 3Moderate to Severe Atopic Dermatitis

MethotrexatePlacebo

medac GmbH277 participants30 sites · Czechia, France, ItalyCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

Phase 1Atopic Dermatitis (AD)

Onabotulinum Toxin Type A - Phase 1bOnabotulinum Toxin Type A - Phase 2

Daniel Kaplan8 participants2 sites · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis

N/AAtopic Dermatitis (AD)

CeraVe Moisturizing CreamGalenico

Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse98 participants1 site · ItalyCompletes Jul 2026

Compare CT.gov Full analysis →

Recruiting

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

Phase 1Atopic DermatitisHidradenitis Suppurativa (HS)Rheumatoid Arthritis (RA)

QLS12010Placebo

Shanghai Qilu Pharmaceutical Research and Development Center LTD102 participants1 site · ChinaCompletes Dec 2025

Compare CT.gov Full analysis →

1–15 of 236